Pay in 4 interest-free payments of $5.78 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
Disclosures: Pedro Ochoa-Allemant: Nothing to Disclose, Rebecca Hubbard: Nothing to Disclose, David Kaplan: AstraZeneca Inc: Grant/Research Support, Roche Genentech: Independent Contractor, Exact Sciences: Grant/Research Support, Glycotest: Grant/Research Support, Sirtex: Advisor, Exelixis: Advisor, AstraZeneca: Advisor, Marina Serper: Transplant Genomics: Grant/Research Support, Grifols: Grant/Research Support, Eurofins: Grant/Research Support 1066 ANALYSIS OF THE DISTRIBUTION AND SEVERITY OF LIVER FIBROSIS STAGES AMONG THE LOCAL POPULATION WITHIN THE RIO GRANDE VALLEY: IDENTIFICATION OF RISK FACTORS AND ACCURACY OF NON-INVASIVE DIAGNOSTIC TOOLS Dimple Desai Rashmee Patil 1 , 1 South Texas Research Institute Background: In the Rio Grande Valley of South Texas, a region with a high prevalence of metabolic disorders such as diabetes, obesity, and hypertension, liver fibrosis presents as a significant health challenge in the Hispanic population
This cardiovascular benefit reflects weight loss, improved glucose control, and direct effects on vascular function
HYGIENE A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS A61P35/00Antineoplastic agents AHUMAN NECESSITIES A61MEDICAL OR VETERINARY SCIENCE
Dehydration Lower fluid intake, nausea, or vomiting can all contribute to tiredness
US$ 23.11
US$ 23.56
:max_bytes(150000):strip_icc()/Common-Symptoms-From-Taking-a-GLP-1-And-How-to-Manage-Them-9e5bb7cee0484522a50dd9d7ce954cc4.jpg)
US$ 23.21
